Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(20%)
Results Posted
100%(2 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_2
1
20%
Ph not_applicable
1
20%
Ph phase_3
1
20%
Ph phase_4
2
40%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)
N/A1 (20.0%)

Trials by Status

completed240%
recruiting120%
terminated120%
unknown120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_3

Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia

NCT06020495
terminatedphase_2

DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty

NCT01982760
unknownphase_4

DDAVP vs. Exercise in Patients With Mild Hemophilia A

NCT03136003
completedphase_4

1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy

NCT00748072
completednot_applicable

Platelet Function Analysis in Head Trauma: ASA/Plavix

NCT01534117

Clinical Trials (5)

Showing 5 of 5 trials
NCT06020495Phase 3

Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia

Recruiting
NCT01982760Phase 2

DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty

Terminated
NCT03136003Phase 4

DDAVP vs. Exercise in Patients With Mild Hemophilia A

Unknown
NCT00748072Phase 4

1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy

Completed
NCT01534117Not Applicable

Platelet Function Analysis in Head Trauma: ASA/Plavix

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5